We develop, manufacture and distribute radiopharmaceutical products that meet industry-leading standards in quality, efficacy and innovation.

Xenopia specialises in the production and supply of radioactive tracers used in nuclear medicine. By potentially enabling accurate early diagnosis and treatment of cancer, as well as heart, brain and bone diseases, our world-class products empower our customers with effective treatment, and proven patient outcomes.

We believe in building long-term partnerships that drive sustainable growth for our customers.

We ensure this via the following:-